<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>8(23)</volume><submitter>Wichert MC</submitter><journal>Blood advances</journal><pagination>6035-6042</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11635643</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>The dual BCL-2 and BCL-XL inhibitor AZD4320 acts on-target and synergizes with MCL-1 inhibition in B-cell precursor ALL.</pubmed_title><pmcid>PMC11635643</pmcid><pubmed_authors>Niedermayer A</pubmed_authors><pubmed_authors>Meyer LH</pubmed_authors><pubmed_authors>Seyfried F</pubmed_authors><pubmed_authors>Debatin KM</pubmed_authors><pubmed_authors>Bender J</pubmed_authors><pubmed_authors>Enzenmuller S</pubmed_authors><pubmed_authors>Fortner C</pubmed_authors><pubmed_authors>Wichert MC</pubmed_authors></additional><is_claimable>false</is_claimable><name>The dual BCL-2 and BCL-XL inhibitor AZD4320 acts on-target and synergizes with MCL-1 inhibition in B-cell precursor ALL.</name><description/><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Dec</publication><modification>2025-04-04T01:37:14.202Z</modification><creation>2025-04-04T01:37:14.202Z</creation></dates><accession>S-EPMC11635643</accession><cross_references><pubmed>39368805</pubmed><doi>10.1182/bloodadvances.2024013194</doi></cross_references></HashMap>